OptimizeRX (OPRX) PT Raised to $25 at Roth Capital Following Announced Medicom Health Partnership
Tweet Send to a Friend
Roth Capital analyst Richard Baldry raised the price target on OptimizeRX (NASDAQ: OPRX) to $25.00 (from $22.50) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
